Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.
Press releases published on June 18, 2025
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
GlobeNewswire
·
June 18, 2025
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing is pleased to announce an offering …
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
GlobeNewswire
·
June 18, 2025
New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant- …
Kane Biotech Provides Further Corporate Update
GlobeNewswire
·
June 18, 2025
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates on its reorganizational phase. The Company has terminated its exclusive distribution agreement with ProgenaCare …
BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs
GlobeNewswire
·
June 18, 2025
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco360®, has been selected as the national pharmacy partner …
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
GlobeNewswire
·
June 18, 2025
FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a one-for- …
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
GlobeNewswire
·
June 18, 2025
SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), …
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
GlobeNewswire
·
June 18, 2025
Dr. Clark Brings 25 Years of Experience Treating Retina Diseases and Developing Emerging Therapies as a Principal Investigator in Over 70 Clinical Trials and as an Early Pioneer of VEGF Inhibitors ANX007 is the Only Investigational Program Shown to …
Galapagos presenteerde nieuwe gegevens op ICML 2025 van Cohort 3 van de ATALANTA-1 studie bij patiënten met recidief/refractair indolent NHL, en toonde hoge complete respons- en MRD-negativiteitspercentages aan met de CAR-T-kandidaat GLPG51
GlobeNewswire
·
June 18, 2025
Van de 34 patiënten die werden ingeschreven in Cohort 3 van de ATALANTA-1 fase 1/2-studie, ontvingen er 32 GLPG5101; 94% kreeg verse CAR T-cellen toegediend, en 93% werd behandeld binnen zeven dagen na productie GLPG5101 toonde veelbelovende werkzaamheid …
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
GlobeNewswire
·
June 18, 2025
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing GLPG5101 demonstrated promising efficacy with durable CAR-T …
OnlineSemaglutide.org Launches Platform Offering Easy Access to GLP-1 Medications
GlobeNewswire
·
June 18, 2025
San Diego, CA, June 18, 2025 (GLOBE NEWSWIRE) -- OnlineSemaglutide.org, a leader in the field of Health …
Spine Surgeon Dr. Michael Gallizzi of The Steadman Clinic Achieves Milestone in Robotic and Endoscopic Surgery
GlobeNewswire
·
June 18, 2025
VAIL, Colo., June 18, 2025 (GLOBE NEWSWIRE) -- The Steadman Clinic and Dr. Michael Gallizzi continue to strengthen their reputation as global leaders in advanced surgical technology. Since joining the clinic three years ago, Dr. Gallizzi has performed over …
EarlyHealth Group übernimmt Corena, um ein Wachstum von 100 Millionen US-Dollar im türkischen Life-Sciences-Sektor zu erzielen
GlobeNewswire
·
June 18, 2025
ANKARA, Türkei, June 18, 2025 (GLOBE NEWSWIRE) -- EarlyHealth Group, ein globaler Pharmadienstleister, gab heute die Übernahme von Corena Ecza Deposu, dem führenden Pharmadistributor in der Türkei, bekannt und stärkt damit seine Position als einer der größ …
Excellent Brain Ltd. Announces Joint Venture with MasNeuros to Launch Spanish Neurofeedback Trainers Course
GlobeNewswire
·
June 18, 2025
Natanya, Israel , June 18, 2025 (GLOBE NEWSWIRE) -- Excellent Brain Ltd., an innovative Israeli start-up renowned for its advanced neurofeedback solutions, has announced a strategic joint venture with MasNeuros, a leading Spanish organization. This …
Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight
GlobeNewswire
·
June 18, 2025
New York, USA, June 18, 2025 (GLOBE NEWSWIRE) -- Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight The global surge in diabetes cases is a key factor propelling the artificial …
Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition
GlobeNewswire
·
June 18, 2025
Aliso Viejo, CA , June 18, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., developer of the Life Backup Plan digital health platform, proudly announces its advancement to the second round of Pepperdine University’s Most Fundable Companies® 2025 competition. The …
WellSpan commits $3.5 million to address housing challenges across central Pennsylvania
GlobeNewswire
·
June 18, 2025
York, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Marking its largest community grant investment in housing initiatives to date, WellSpan is inspiring health through a $3.5 million grant commitment over the next three years to support 12 mission-driven, …
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
GlobeNewswire
·
June 18, 2025
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 weeks with dapiglutide escalated up to …
Human Appeal announces summertime UK Comedy Tour
GlobeNewswire
·
June 18, 2025
MANCHESTER, United Kingdom, June 18, 2025 (GLOBE NEWSWIRE) -- Following the roaring success of its annual winter Comedy Tour over the last decade, one of the UK’s leading humanitarian aid charities, Human Appeal, today announces its first ever summertime …
Bay Area Lyme Foundation Announces New Executive Director Josh Wein
GlobeNewswire
·
June 18, 2025
PORTOLA VALLEY, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has hired Josh Wein to serve as its new executive director, positioning the foundation for continued success funding …
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin
GlobeNewswire
·
June 18, 2025
- First use of camel hemoglobin as a universal oxygen carrier - Unique properties make it an ideal ingredient for oxygen transport BOSTON, MASSACHUSETTS, June 18, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage …